Compared to individuals with a fast NAT2 acetyl gene or GSTM1-positive genotype, those with a slow NAT2 acetyl genome or GSTM1-NULL genome have a higher risk of RCC. This evidence concerns the gene GSTM1 and renal cell carcinoma.